← Leaderboards
Jaya Rajaiya
University Of New Mexico Health Scis Ctr
$5,280,022
Attributed
$8,632,869
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $850K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,632,869 · 2
By mechanism
R01$8,632,869 · 2
Top collaborators
- James Chodosh19 shared
Most similar at University Of New Mexico Health Scis Ctr
Same institution · by research overlap
- James Chodosh$11,189,101
Others in their field
Top investigators on “Ocular Surface”
- Darlene A Dartt · Schepens Eye Research Institute$20,088,341
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Sandeep Jain · University Of Illinois At Chicago$14,578,104
- Mary Ann Stepp · George Washington University$13,978,909
- Robert M Lavker · University Of Pennsylvania$13,681,806
- Sarah F Hamm-Alvarez · University Of Southern California$13,173,998
Research focus
Ocular SurfaceAdenovirus InfectionsEye InfectionsCellsViralAdenovirusesSignal TransductionVirusEpidemic KeratoconjunctivitisInfectionCorneaVirus DiseasesCorneal StromaVisual ImpairmentKeratitisDesignPhotophobiaCell TypeInflammationViral DnaVirulentMediatingNuclearSmall Interfering Rna
Grant awards (24)
Novel Mechanisms in Adenoviral Ocular Pathogenesis$324,063
R01 · FY2025 · EY · contact PI
Immunopathogenesis of Adenovirus Keratitis$319,677
R01 · FY2025 · EY
Novel Mechanisms in Adenoviral Ocular Pathogenesis$381,250
R01 · FY2024 · EY · contact PI
Immunopathogenesis of Adenovirus Keratitis$318,602
R01 · FY2024 · EY
Novel Mechanisms in Adenoviral Ocular Pathogenesis$381,250
R01 · FY2023 · EY · contact PI
Immunopathogenesis of Adenovirus Keratitis$318,602
R01 · FY2023 · EY
Novel Mechanisms in Adenoviral Ocular Pathogenesis$385,046
R01 · FY2022 · EY · contact PI
Immunopathogenesis of Adenovirus Keratitis$237,819
R01 · FY2022 · EY
Immunopathogenesis of Adenovirus Keratitis$187,180
R01 · FY2022 · EY
Novel Mechanisms in Adenoviral Ocular Pathogenesis$27,205
R01 · FY2022 · EY · contact PI
Novel Mechanisms in Adenoviral Ocular Pathogenesis$425,000
R01 · FY2021 · EY · contact PI
Endocytosis in Adenoviral Ocular Pathogenesis$425,000
R01 · FY2020 · EY · contact PI
Immunopathogenesis of Adenovirus Keratitis$425,000
R01 · FY2020 · EY
Immunopathogenesis of Adenovirus Keratitis$425,000
R01 · FY2019 · EY
Endocytosis in Adenoviral Ocular Pathogenesis$425,000
R01 · FY2019 · EY · contact PI
Endocytosis in Adenoviral Ocular Pathogenesis$425,000
R01 · FY2018 · EY · contact PI
Immunopathogenesis of Adenovirus Keratitis$425,000
R01 · FY2018 · EY
Immunopathogenesis of Adenovirus Keratitis$425,000
R01 · FY2017 · EY
Endocytosis in Adenoviral Ocular Pathogenesis$425,000
R01 · FY2017 · EY · contact PI
Lipid Rafts in Adenoviral Ocular Pathogenesis$384,650
R01 · FY2015 · EY · contact PI
Lipid Rafts in Adenoviral Ocular Pathogenesis$384,650
R01 · FY2014 · EY · contact PI
Lipid Rafts in Adenoviral Ocular Pathogenesis$372,875
R01 · FY2013 · EY · contact PI
Lipid Rafts in Adenoviral Ocular Pathogenesis$392,500
R01 · FY2012 · EY · contact PI
Lipid Rafts in Adenoviral Ocular Pathogenesis$392,500
R01 · FY2011 · EY · contact PI